These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 20554745)
21. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Bowden GT; Schneider B; Domann R; Kulesz-Martin M Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304 [TBL] [Abstract][Full Text] [Related]
22. Innovative agents for actinic keratosis and nanocarriers enhancing skin penetration. Schäfer-Korting M; Höltje M; Korting HC; Höltje HD Skin Pharmacol Physiol; 2010; 23(1):6-14. PubMed ID: 20090403 [TBL] [Abstract][Full Text] [Related]
23. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin. Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877 [TBL] [Abstract][Full Text] [Related]
24. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression. Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500 [TBL] [Abstract][Full Text] [Related]
25. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521 [TBL] [Abstract][Full Text] [Related]
26. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971 [TBL] [Abstract][Full Text] [Related]
27. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Sumita N; Bito T; Nakajima K; Nishigori C Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876 [TBL] [Abstract][Full Text] [Related]
28. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Paolino D; Celia C; Trapasso E; Cilurzo F; Fresta M Eur J Pharm Biopharm; 2012 May; 81(1):102-12. PubMed ID: 22414731 [TBL] [Abstract][Full Text] [Related]
29. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse. Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090 [TBL] [Abstract][Full Text] [Related]
30. Emerging drugs for actinic keratosis. Ulrich M; Drecoll U; Stockfleth E Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178 [TBL] [Abstract][Full Text] [Related]
31. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981 [TBL] [Abstract][Full Text] [Related]
32. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Yokota K; Gill TJ; Shinozuka H Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029 [TBL] [Abstract][Full Text] [Related]
33. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms. Zhang X; Egawa K; Xie Y; Ihn H Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364 [TBL] [Abstract][Full Text] [Related]
34. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. Williams IR; Ort RJ; Daley D; Manning L; Karaoli T; Barnhill RL; Kupper TS J Immunol; 1996 May; 156(9):3382-8. PubMed ID: 8617964 [TBL] [Abstract][Full Text] [Related]
35. Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in Vivo. Rottboell L; de Foenss S; Thomsen K; Christiansen H; Andersen SM; Dam TN; Rosada C; Stenderup K Dermatol Reports; 2015 Dec; 7(3):6246. PubMed ID: 26734122 [TBL] [Abstract][Full Text] [Related]
36. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Katiyar SK; Agarwal R; Mukhtar H Cancer Res; 1993 Nov; 53(22):5409-12. PubMed ID: 8221679 [TBL] [Abstract][Full Text] [Related]
37. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience. Wang XL; Wang HW; Guo MX; Xu SZ Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):127-33. PubMed ID: 19356643 [TBL] [Abstract][Full Text] [Related]
38. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Owens DM; Watt FM Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366 [TBL] [Abstract][Full Text] [Related]
39. Response of carcinoma in situ (actinic keratosis) to green tea concentrate plus capsicum. Morré DJ; Geilen CC; Welch AM; Morré DM J Diet Suppl; 2009; 6(4):385-9. PubMed ID: 22435520 [TBL] [Abstract][Full Text] [Related]
40. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6. Woelfle U; Laszczyk MN; Kraus M; Leuner K; Kersten A; Simon-Haarhaus B; Scheffler A; Martin SF; Müller WE; Nashan D; Schempp CM J Invest Dermatol; 2010 Jan; 130(1):113-23. PubMed ID: 19675576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]